Healthcare provider profile · identity verified

Ira Jay Hollander, MD

Internal Medicine · BROOKLYN, NY · NPI 1528072576

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Amlodipine Besylate	Amlodipine Besylate	417	118
Atorvastatin Calcium	Atorvastatin Calcium	378	93
Levothyroxine Sodium	Levothyroxine Sodium	376	85
Rosuvastatin Calcium	Rosuvastatin Calcium	317	92
Losartan Potassium	Losartan Potassium	272	79
Metoprolol Succinate	Metoprolol Succinate	258	66
Simvastatin	Simvastatin	245	60
Eliquis	Apixaban	224	41
Metformin Hcl Er	Metformin Hcl	191	53
Furosemide	Furosemide	174	46
Ramipril	Ramipril	157	42
Pantoprazole Sodium	Pantoprazole Sodium	155	41
Lisinopril	Lisinopril	149	41
Famotidine	Famotidine	125	39
Hydrochlorothiazide	Hydrochlorothiazide	124	38
Gabapentin	Gabapentin	120	45
Tamsulosin Hcl	Tamsulosin Hcl	119	34
Fluticasone Propionate	Fluticasone Propionate	109	41
Omeprazole	Omeprazole	103	30
Azelastine Hcl	Azelastine Hcl	102	46
Atenolol	Atenolol	87	20
Escitalopram Oxalate	Escitalopram Oxalate	87	26
Trazodone Hcl	Trazodone Hcl	82	27
Valsartan	Valsartan	79	15
Allopurinol	Allopurinol	77	18
Ozempic	Semaglutide	77	14
Spironolactone	Spironolactone	71	20
Metformin Hcl	Metformin Hcl	68	17
Potassium Chloride	Potassium Chloride	67	19
Buspirone Hcl	Buspirone Hcl	66	20
Januvia	Sitagliptin Phosphate	65	14
Montelukast Sodium	Montelukast Sodium	65	12
Doxycycline Hyclate	Doxycycline Hyclate	63	53
Jardiance	Empagliflozin	61	12
Ketoconazole	Ketoconazole	61	26
Irbesartan	Irbesartan	60	14
Zolpidem Tartrate	Zolpidem Tartrate	59	15
Mounjaro	Tirzepatide	57	14
Synthroid	Levothyroxine Sodium	57	17
Pravastatin Sodium	Pravastatin Sodium	56	17
Glimepiride	Glimepiride	54	14
Olmesartan Medoxomil	Olmesartan Medoxomil	49	12
Hydralazine Hcl	Hydralazine Hcl	48	13
Mupirocin	Mupirocin	48	26
Myrbetriq	Mirabegron	48	12
Albuterol Sulfate Hfa	Albuterol Sulfate	46	16
Farxiga	Dapagliflozin Propanediol	45	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	45	suppressed
Sertraline Hcl	Sertraline Hcl	45	suppressed
Ezetimibe	Ezetimibe	44	suppressed
Finasteride	Finasteride	43	16
Carvedilol	Carvedilol	41	11
Enalapril Maleate	Enalapril Maleate	41	12
Azithromycin	Azithromycin	39	37
Xarelto	Rivaroxaban	39	suppressed
Alprazolam	Alprazolam	38	12
Clopidogrel	Clopidogrel Bisulfate	35	suppressed
Tradjenta	Linagliptin	35	suppressed
Clonazepam	Clonazepam	34	13
Cephalexin	Cephalexin	33	16
Doxazosin Mesylate	Doxazosin Mesylate	33	suppressed
Torsemide	Torsemide	33	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	30	15
Meclizine Hcl	Meclizine Hcl	30	19
Pitavastatin Calcium	Pitavastatin Calcium	30	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	29	suppressed
Mometasone Furoate	Mometasone Furoate	28	18
Triamcinolone Acetonide	Triamcinolone Acetonide	27	suppressed
Citalopram Hbr	Citalopram Hydrobromide	26	suppressed
Cefdinir	Cefdinir	25	19
Bupropion Xl	Bupropion Hcl	24	suppressed
Duloxetine Hcl	Duloxetine Hcl	24	suppressed
Icosapent Ethyl	Icosapent Ethyl	24	suppressed
Prednisone	Prednisone	24	suppressed
Folic Acid	Folic Acid	23	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Lactulose	Lactulose	20	suppressed
Repatha Sureclick	Evolocumab	20	suppressed
Sucralfate	Sucralfate	20	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Terazosin Hcl	Terazosin Hcl	19	suppressed
Tramadol Hcl	Tramadol Hcl	19	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	18	13
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	18	18
Nitroglycerin Patch	Nitroglycerin	18	suppressed
Entresto	Sacubitril/Valsartan	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Alendronate Sodium	Alendronate Sodium	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	16	14
Celecoxib	Celecoxib	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	16	suppressed
Donepezil Hcl	Donepezil Hcl	16	suppressed
Ipratropium Bromide	Ipratropium Bromide	16	suppressed
Rybelsus	Semaglutide	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	15	15
Propranolol Hcl	Propranolol Hcl	15	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Benazepril Hcl	Benazepril Hcl	14	suppressed
Meloxicam	Meloxicam	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Nitroglycerin	Nitroglycerin	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Crestor	Rosuvastatin Calcium	13	suppressed
Dilantin	Phenytoin Sodium Extended	13	suppressed
Enoxaparin Sodium	Enoxaparin Sodium	13	suppressed
Flomax	Tamsulosin Hcl	13	suppressed
Hydrocortisone	Hydrocortisone	13	suppressed
Mirtazapine	Mirtazapine	13	suppressed
Nadolol	Nadolol	13	suppressed
Azathioprine	Azathioprine	12	suppressed
Colchicine	Colchicine	12	suppressed
Labetalol Hcl	Labetalol Hcl	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Ofloxacin	Ofloxacin	12	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	12	suppressed
Baclofen	Baclofen	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	11	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error